Ulf Müller‐Ladner

Research interests

Publications

• ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease

  Journal of Crohn s and Colitis · 2023 · https://doi.org/10.1093/ecco-jcc/jjad108

• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

  Annals of the Rheumatic Diseases · 2020 · https://doi.org/10.1136/annrheumdis-2019-216655

• Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis

  Autoimmunity Reviews · 2020 · https://doi.org/10.1016/j.autrev.2020.102458

• Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

  The Lancet Respiratory Medicine · 2020 · https://doi.org/10.1016/s2213-2600(20)30318-0

• 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

  Annals of the Rheumatic Diseases · 2019 · https://doi.org/10.1136/annrheumdis-2019-215882

• Mapping and predicting mortality from systemic sclerosis

  Annals of the Rheumatic Diseases · 2017 · https://doi.org/10.1136/annrheumdis-2017-211448

• Update of EULAR recommendations for the treatment of systemic sclerosis

  Annals of the Rheumatic Diseases · 2016 · https://doi.org/10.1136/annrheumdis-2016-209909

• Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

  The Lancet · 2016 · https://doi.org/10.1016/s0140-6736(16)00232-4

• 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

  Arthritis & Rheumatism · 2013 · https://doi.org/10.1002/art.38098

• Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study

  Annals of the Rheumatic Diseases · 2013 · https://doi.org/10.1136/annrheumdis-2013-203301

• A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study

  Annals of the Rheumatic Diseases · 2013 · https://doi.org/10.1136/annrheumdis-2012-203090

• 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

  Annals of the Rheumatic Diseases · 2013 · https://doi.org/10.1136/annrheumdis-2013-204424

• Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database

  Annals of the Rheumatic Diseases · 2012 · https://doi.org/10.1136/annrheumdis-2011-200742

• EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

  Annals of the Rheumatic Diseases · 2010 · 10.1136/ard.2010.137216

• Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

  Annals of the Rheumatic Diseases · 2010 · https://doi.org/10.1136/ard.2010.136929

• Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

  Annals of the Rheumatic Diseases · 2010 · https://doi.org/10.1136/ard.2009.114264

• Rheumatoid arthritis progression mediated by activated synovial fibroblasts

  Trends in Molecular Medicine · 2010 · https://doi.org/10.1016/j.molmed.2010.07.004

• EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)

  Annals of the Rheumatic Diseases · 2009 · https://doi.org/10.1136/ard.2008.096677

• Synovial fibroblasts spread rheumatoid arthritis to unaffected joints

  Nature Medicine · 2009 · https://doi.org/10.1038/nm.2050

• Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative

  Annals of the Rheumatic Diseases · 2008 · https://doi.org/10.1136/ard.2008.094474

• The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement

  Lara D. Veeken · 2008 · https://doi.org/10.1093/rheumatology/ken179

• Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

  Annals of the Rheumatic Diseases · 2007 · https://doi.org/10.1136/ard.2006.062901

• Mechanisms of Disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis

  Nature Clinical Practice Rheumatology · 2005 · https://doi.org/10.1038/ncprheum0047

• Uncontrolled Expression of Vascular Endothelial Growth Factor and Its Receptors Leads to Insufficient Skin Angiogenesis in Patients With Systemic Sclerosis

  Circulation Research · 2004 · https://doi.org/10.1161/01.res.0000134644.89917.96

• Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice.

  PubMed · 1996

Current projects

No projects listed.